首页> 外文OA文献 >Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg- -Naphthylamide-Inhibitable Efflux Pumps

【2h】

Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg- -Naphthylamide-Inhibitable Efflux Pumps

机译：与炎症性肠病相关的大肠杆菌中的利福昔突抗性与先前的利福昔氨姻使用，RPOB中的突变以及Phe-Arg-萘酰胺抑制泵的活性相关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
V. Kothary; E. J. Scherl; B. Bosworth; Z.-D. Jiang; H. L. DuPont; J. Harel; K. W. Simpson; B. Dogan;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg-β-Naphthylamide-Inhibitable Efflux Pumps [J] . KotharyV., ScherlE.J., BosworthB., Antimicrobial agents and chemotherapy. . 2013,第2期

机译：与炎症性肠病相关的大肠杆菌中的利福昔明抗性与先前的利福昔明使用，rpoB突变以及Phe-Arg-β-萘酰胺抑制性外排泵的活性相关。
2. Relevant role of efflux pumps in high levels of rifaximin resistance in Escherichia coli clinical isolates. [J] . C Gomes, L Ruiz, M J Pons, Transactions of the Royal Society of Tropical Medicine and Hygiene . 2013,第9期

机译：外排泵在大肠杆菌临床分离株中高水平的利福昔明耐药性中的相关作用。
3. Relevant role of efflux pumps in high levels of rifaximin resistance in Escherichia coli clinical isolates. [J] . C Gomes, L Ruiz, M J Pons, Transactions of the Royal Society of Tropical Medicine and Hygiene . 2013,第9期

机译：Escherichia Coli临床分离株高水平利福昔突耐力血清素抗性的相关作用。
4. Exploring Mutations in the GPR65 Locus as Predictors of Risk and Activity for Inflammatory Bowel Disease [D] . ?Duncan, Michael A. 2020

机译：探索GPR65基因座中的突变作为炎症性肠病风险和活性的预测因子
5. Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use Mutations in rpoB and Activity of Phe-Arg-β-Naphthylamide-Inhibitable Efflux Pumps [O] . Vishesh Kothary, Ellen J. Scherl, Brian Bosworth, 2013

机译：大肠埃希菌与炎症性肠病相关的耐药性与先前使用利福昔明rpoB突变以及Phe-Arg-β-萘酰胺抑制性外排泵的活性相关。
6. Review article: the potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases [O] . R. B. Sartor 2015

机译：审查文章：利福昔明在炎症性肠病管理中的潜在机制

Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg- -Naphthylamide-Inhibitable Efflux Pumps

著录项

相似文献

相关主题

期刊订阅